Christopher A. Kroeger

Chief Executive Officer · MapLight Therapeutics

Christopher A. Kroeger (Chief Executive Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in MapLight Therapeutics, Inc. (MPLT). The largest single filing was $5.4M of MPLT (147,457 sh across 5 lots, as filed), executed Jul 15. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 6 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$12.8M

shares × price, as filed

Last traded

Oct 15

Filed Oct 16

Median ADV $7.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $12.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 6 filings

Sector per market data · by filing · past 12 months

Most traded names

MPLT

MapLight Therapeutics, Inc. MPLT · 0 buys · 6 sells 6 filings

Recent filings

MPLTSALE MapLight Therapeutics, Inc. View filing → $595K
73,691 sh × $8.08
Exec Oct 15
Filed Oct 16 · 5:00 PM ET MPLTSALE MapLight Therapeutics, Inc. View filing → $5.4M
147,457 sh across 5 lots
Exec Jul 15
Filed Jul 17 · 9:46 PM ET MPLTSALE MapLight Therapeutics, Inc. View filing → $3.2M
118,037 sh × $27.19
Exec May 18
Filed May 18 · 5:30 PM ET MPLTSALE MapLight Therapeutics, Inc. View filing → $1.8M
62,485 sh across 5 lots
Exec May 7
Filed May 11 · 5:30 PM ET MPLTSALE MapLight Therapeutics, Inc. View filing → $1.4M
47,808 sh across 5 lots
Exec May 4
Filed May 6 · 5:30 PM ET MPLTSALE MapLight Therapeutics, Inc. View filing → $454K
16,710 sh across 2 lots
Exec Apr 15
Filed Apr 17 · 5:30 PM ET